Evidence map›Paper›PMID 25274727›Full record

ArticleGenes & development2014

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation.

François Le Dily, Davide Baù, Andy Pohl, Guillermo P Vicent, François Serra, Daniel Soronellas, Giancarlo Castellano, Roni H G Wright, Cecilia Ballare, Guillaume Filion and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 1 synthesis or guideline pooled it, 332 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

François Le DilyGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), 08028 Barcelona, Spain;
Davide BaùGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), 08028 Barcelona, Spain;
Andy PohlGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain;
Guillermo P VicentGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain;
François SerraGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), 08028 Barcelona, Spain;
Daniel SoronellasGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain;
Giancarlo CastellanoGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain; Hospital Clínic, Universitat de Barcelona, 08036 Barcelona, Spain;
Roni H G WrightGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain;
Cecilia BallareGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain;
Guillaume FilionGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain;
Marc A Marti-RenomGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), 08028 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.
Miguel BeatoGene Regulacion, Stem Cells, and Cancer Program, Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain; miguel.beato@crg.es mmarti@pcb.ub.cat.
Pompeu Fabra University · ESCentre for Genomic Regulation · ESCentro Nacional de Análisis Genómico · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human genome is segmented into topologically associating domains (TADs), but the role of this conserved organization during transient changes in gene expression is not known. Here we describe the distribution of progestin-induced chromatin modifications and changes in transcriptional activity over TADs in T47D breast cancer cells. Using ChIP-seq (chromatin immunoprecipitation combined with high-throughput sequencing), Hi-C (chromosome capture followed by high-throughput sequencing), and three-dimensional (3D) modeling techniques, we found that the borders of the ∼ 2000 TADs in these cells are largely maintained after hormone treatment and that up to 20% of the TADs could be considered as discrete regulatory units where the majority of the genes are either transcriptionally activated or repressed in a coordinated fashion. The epigenetic signatures of the TADs are homogeneously modified by hormones in correlation with the transcriptional changes. Hormone-induced changes in gene activity and chromatin remodeling are accompanied by differential structural changes for activated and repressed TADs, as reflected by specific and opposite changes in the strength of intra-TAD interactions within responsive TADs. Indeed, 3D modeling of the Hi-C data suggested that the structure of TADs was modified upon treatment. The differential responses of TADs to progestins and estrogens suggest that TADs could function as "regulons" to enable spatially proximal genes to be coordinately transcribed in response to hormones.

Indexed as

Cell Line, TumorChromatinChromatin Assembly and DisassemblyGene Expression RegulationHormonesHumansProgestinsChromatinHormonesProgestinsepigenetic landscapegene expressionHi-Cprogesterone receptorTADsthree-dimensional structure of the genometranscriptional regulation

Identifiers

PMID25274727
PMCPMC4180976
OpenAlexW2137601569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.